KGbio
@kg-biologics.com
Welcome to KGbio - Clinical-stage biotech company Backed by Kalbe and Genexine and US private equity giant General Atlantic. Licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas and also contract manufacturing.
KGbio's Company Logos
KGbio's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#7DBF3F
Sushi
125, 191, 63
91, 50, 50
35, 0, 67, 25
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#080808
Cod Gray
8, 8, 8
0, 0, 3
0, 0, 0, 97
About KGbio
Welcome to KGbio, a clinical-stage biotech company backed by Kalbe, Genexine, and General Atlantic. Our mission is to bring biologics medical innovation to the international market. At KGbio, we specialize in licensing novel biologics and biosimilars in the fields of oncology and high-specialty therapeutic areas.
Additionally, we offer contract manufacturing services, providing cGMP development and manufacturing as pioneers in biopharmaceuticals in Indonesia. Our team consists of experienced professionals with diverse backgrounds and expertise, fostering a culture of collaboration, excellence, and accountability. We are dedicated to improving patient outcomes and quality of life through our products.
Our portfolio encompasses a wide range of therapeutic areas, including oncology and high specialty areas. Stay up-to-date with the latest news from KGbio, such as the recent approval of our product, Trazher 150 mg Powder for Concentrate for Solution for Infusion in Singapore. We strive for innovation and are constantly pushing the boundaries of biotech to make a positive impact on global healthcare.
Join us on our journey and become part of KGbio's success. Visit our website to learn more about our company, products, and career opportunities
